Answer
Yes, Granocyte (lenograstim) must not be administered to patients aged below 55 years with de novo acute myeloid leukaemia.
Sources for this answer
- Granocyte 13 million IU, and 34 million IUChugai Pharma UK Limited · emc · SmPC §4.3 Contraindications · Version 22Document updated
Sources checked